ArticleChinese journal of integrative medicine2026
Maxing Shigan Decoction Regulates Immune Inflammatory Response of Adenovirus Pneumonia by Inhibiting cGAS-STING Pathway.
Article in Chinese journal of integrative medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate whether Maxing Shigan Decoction (MSD) regulates the immune-inflammatory response of adenovirus pneumonia (AVP) by inhibiting the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway.
methodsA mouse model of AVP was induced by intranasal instillation of human adenovirus type 3 (Ad3), and Raw264.7 cells were infected with Ad3 to establish an in vitro model. The in vivo and in vitro experiments both included 6 groups: control, model, ribavirin (RIB), and low- (MSD-L), medium- (MSD-M), and high-dose MSD (MSD-H) groups. Moreover, the cGAS-STING pathway agonist SR-717 was used during the cell experiment. Hematoxylin and eosin (HE) staining was conducted to identify pathological changes in the lung tissue of AVP mice. The quantity of CD3
resultsIn vivo, MSD and RIB significantly reduced lung tissue inflammation in the AVP mouse model, and reduced the excessive immune response mediated by CD3
conclusionsMSD modulated the immune inflammatory response in AVP by inhibiting the cGAS-STING pathway. It protected lung tissue from damage caused by excessive immune responses and inflammatory reactions.
Indexed as
Identifiers
42859372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.